Evidence map›Paper›PMID 24784232›Full record

ArticleNature medicine2014

A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity.

David J Marchant, Caroline L Bellac, Theo J Moraes, Samuel J Wadsworth, Antoine Dufour, Georgina S Butler, Leanne M Bilawchuk, Reid G Hendry, A Gordon Robertson, Caroline T Cheung and 16 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 261 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 2 countries.

David J Marchant1] Department of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada. [2] Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Caroline L Bellac1] Department of Oral Biological & Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. [2] Department of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada. [3] Centre for Blood Research, Life Sciences Institute, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.
Theo J MoraesDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Samuel J WadsworthDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Antoine Dufour1] Department of Oral Biological & Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. [2] Department of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada. [3] Centre for Blood Research, Life Sciences Institute, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.
Georgina S Butler1] Department of Oral Biological & Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. [2] Department of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada. [3] Centre for Blood Research, Life Sciences Institute, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.
Leanne M BilawchukLi Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Reid G HendryLi Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
A Gordon RobertsonCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Caroline T CheungDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Julie NgDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Lisa AngDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Zongshu LuoDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Karl HeilbronDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Michael J NorrisDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Wenming DuanDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Taylor BucykLi Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
Andrei KarpovDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Laurent DevelCommissariat a l'Energie Atomique, Labex LERMIT, Service d'Ingenierie Moleculaire des Proteines, Gif/Yvette, France.
Dimitris Georgiadis1] Commissariat a l'Energie Atomique, Labex LERMIT, Service d'Ingenierie Moleculaire des Proteines, Gif/Yvette, France. [2].
Richard G HegeleDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Honglin LuoDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
David J GranvilleDepartment of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada.
Vincent DiveCommissariat a l'Energie Atomique, Labex LERMIT, Service d'Ingenierie Moleculaire des Proteines, Gif/Yvette, France.
Bruce M McManus1] Department of Pathology and Laboratory Medicine, UBC James Hogg Research Centre, Institute for Heart + Lung Health, St. Paul's Hospital/Providence Health Care/University of British Columbia, Vancouver, British Columbia, Canada. [2].
Christopher M Overall1] Department of Oral Biological & Medical Sciences, University of British Columbia, Vancouver, British Columbia, Canada. [2] Department of Biochemistry & Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada. [3] Centre for Blood Research, Life Sciences Institute, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada. [4].
St. Paul's Hospital · CAUniversity of British Columbia · CAUniversity of Toronto · CAUniversity of Alberta · CACommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCanada's Michael Smith Genome Sciences Centre · CALaboratoire d'Excellence en Recherche sur le Médicament et l'Innovation ThérapeutiqueProvidence Health Care · CA

Funding

Canadian Institutes of Health Research 08-0369Canadian Institutes of Health Research MOP-111055Canadian Institutes of Health Research MOP-37937
6 · The paper itself

Abstract

Interferon-α (IFN-α) is essential for antiviral immunity, but in the absence of matrix metalloproteinase-12 (MMP-12) or IκBα (encoded by NFKBIA) we show that IFN-α is retained in the cytosol of virus-infected cells and is not secreted. Our findings suggest that activated IκBα mediates the export of IFN-α from virus-infected cells and that the inability of cells in Mmp12(-/-) but not wild-type mice to express IκBα and thus export IFN-α makes coxsackievirus type B3 infection lethal and renders respiratory syncytial virus more pathogenic. We show here that after macrophage secretion, MMP-12 is transported into virus-infected cells. In HeLa cells MMP-12 is also translocated to the nucleus, where it binds to the NFKBIA promoter, driving transcription. We also identified dual-regulated substrates that are repressed both by MMP-12 binding to the substrate's gene exons and by MMP-12-mediated cleavage of the substrate protein itself. Whereas intracellular MMP-12 mediates NFKBIA transcription, leading to IFN-α secretion and host protection, extracellular MMP-12 cleaves off the IFN-α receptor 2 binding site of systemic IFN-α, preventing an unchecked immune response. Consistent with an unexpected role for MMP-12 in clearing systemic IFN-α, treatment of coxsackievirus type B3-infected wild-type mice with a membrane-impermeable MMP-12 inhibitor elevates systemic IFN-α levels and reduces viral replication in pancreas while sparing intracellular MMP-12. These findings suggest that inhibiting extracellular MMP-12 could be a new avenue for the development of antiviral treatments.

Indexed as

AnimalsBinding SitesCell NucleusCytosolHeLa CellsHumansI-kappa B ProteinsImmunityInterferon-alphaMatrix Metalloproteinase 12MiceMice, KnockoutNF-KappaB Inhibitor alphaPancreasRous sarcoma virusVirus ReplicationI-kappa B ProteinsInterferon-alphaMatrix Metalloproteinase 12NF-KappaB Inhibitor alphaNFKBIA protein, humanNfkbia protein, mouse

Identifiers

PMID24784232
OpenAlexW2170092045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.